Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Field, Chani R."'
Autor:
Parker, Wendy T. *, Yeung, David T.O., Yeoman, Alexandra L., Altamura, Haley K., Jamison, Bronte A., Field, Chani R., Hodgson, J. Graeme, Lustgarten, Stephanie, Rivera, Victor M., Hughes, Timothy P., Branford, Susan
Publikováno v:
In Blood 14 April 2016 127(15):1870-1880
Autor:
Branford, Susan *, Yeung, David T., Ross, David M., Prime, Jodi A., Field, Chani R., Altamura, Haley K., Yeoman, Alexandra L., Georgievski, Jasmina, Jamison, Bronte A., Phillis, Stuart, Sullivan, Brad, Briggs, Nancy E., Hertzberg, Mark, Seymour, John F., Reynolds, John, Hughes, Timothy P.
Publikováno v:
In Blood 9 May 2013 121(19):3818-3824
Autor:
Parker, Wendy T., Yeung, David T.O., Yeoman, Alexandra L., Altamura, Haley K., Jamison, Bronte A., Field, Chani R., Hodgson, J. Graeme, Lustgarten, Stephanie, Rivera, Victor M., Hughes, Timothy P., Branford, Susan
Publikováno v:
Blood; April 2016, Vol. 127 Issue: 15 p1870-1880, 11p
Autor:
Chani Field, Susan Branford, J. Graeme Hodgson, Timothy P. Hughes, Bronte A. Jamison, Victor M. Rivera, Stephanie Lustgarten, Alexandra L. Yeoman, David T Yeung, Haley Altamura, Wendy T Parker
Publikováno v:
Blood. 127:1870-1880
The third-generation tyrosine kinase inhibitor (TKI) ponatinib shows activity against all common BCR-ABL1 single mutants, including the highly resistant BCR-ABL1-T315I mutant, improving outcome for patients with refractory chronic myeloid leukemia (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4b68d3ac6b5526d8b996d5da9603bb
https://doi.org/10.1182/blood-2015-09-666214
https://doi.org/10.1182/blood-2015-09-666214